Qiming Xu

1.4k total citations
25 papers, 1.2k citations indexed

About

Qiming Xu is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Qiming Xu has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Immunology. Recurrent topics in Qiming Xu's work include Antimicrobial agents and applications (6 papers), Inflammasome and immune disorders (5 papers) and interferon and immune responses (4 papers). Qiming Xu is often cited by papers focused on Antimicrobial agents and applications (6 papers), Inflammasome and immune disorders (5 papers) and interferon and immune responses (4 papers). Qiming Xu collaborates with scholars based in China, United States and Bulgaria. Qiming Xu's co-authors include Zhiqiang Zheng, Hailei Mao, Jiangna Guo, Feng Yan, Jing Qin, Bin Wang, Feng Yan, Hao Cheng, Hong Yuan and Xiangshi Tan and has published in prestigious journals such as Blood, Langmuir and Chemical Communications.

In The Last Decade

Qiming Xu

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiming Xu China 12 343 304 285 285 203 25 1.2k
Xiaoqian Feng China 25 175 0.5× 268 0.9× 201 0.7× 73 0.3× 297 1.5× 69 1.4k
Hailei Mao China 23 519 1.5× 548 1.8× 364 1.3× 33 0.1× 414 2.0× 39 1.8k
Xiaochen Liu China 19 138 0.4× 213 0.7× 349 1.2× 16 0.1× 328 1.6× 73 1.6k
Shuyan Han China 20 194 0.6× 335 1.1× 82 0.3× 73 0.3× 516 2.5× 40 1.7k
Hongzhen Bai China 20 128 0.4× 496 1.6× 28 0.1× 157 0.6× 726 3.6× 50 1.5k
Tianqi Nie China 22 149 0.4× 357 1.2× 17 0.1× 182 0.6× 602 3.0× 43 1.4k
Rafał Konefał Czechia 22 422 1.2× 217 0.7× 35 0.1× 82 0.3× 513 2.5× 99 1.7k
Kaiyue Xu China 15 71 0.2× 288 0.9× 56 0.2× 36 0.1× 127 0.6× 33 728
Yixuan Zhou China 16 365 1.1× 379 1.2× 57 0.2× 47 0.2× 69 0.3× 39 923

Countries citing papers authored by Qiming Xu

Since Specialization
Citations

This map shows the geographic impact of Qiming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiming Xu more than expected).

Fields of papers citing papers by Qiming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiming Xu. The network helps show where Qiming Xu may publish in the future.

Co-authorship network of co-authors of Qiming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiming Xu. A scholar is included among the top collaborators of Qiming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiming Xu. Qiming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Qiming, et al.. (2025). Vaccarin Ameliorates Renal Fibrosis by Inhibiting Ferroptosis via Nrf2/SLC7A11/GPX4 Signaling Pathway. Drug Design Development and Therapy. Volume 19. 1609–1626. 3 indexed citations
3.
Liu, Chang, et al.. (2025). Study on the Pharmacological Efficacy and Mechanism of Dual-Target Liposome Complex AD808 Against Alzheimer’s Disease. Pharmaceuticals. 18(7). 977–977. 1 indexed citations
4.
Patel, Manish, Michael Tees, Nadia Khan, et al.. (2024). IBCL-147 AC676, an Orally Bioavailable BTK Chimeric Degrader in Patients With B-cell Malignancies. Clinical Lymphoma Myeloma & Leukemia. 24. S494–S494. 3 indexed citations
5.
Xu, Qiming, Wenhao Chen, Jie Chen, et al.. (2024). TRIM6 Promotes ROS-Mediated Inflammasome Activation and Pyroptosis in Renal Tubular Epithelial Cells via Ubiquitination and Degradation of GPX3 Protein. Frontiers in Bioscience-Landmark. 29(2). 58–58. 5 indexed citations
7.
Tees, Michael, David A. Bond, Nadia Khan, et al.. (2024). A Phase 1 Study of AC676, a Novel BTK Chimeric Degrader, in Patients with B-Cell Malignancies. Blood. 144(Supplement 1). 4422.1–4422.1. 6 indexed citations
8.
Liao, Lin, Yue Guo, Qiming Xu, et al.. (2022). TRIM46 upregulates Wnt/β-catenin signaling by inhibiting Axin1 to mediate hypoxia-induced epithelial–mesenchymal transition in HK2 cells. Molecular and Cellular Biochemistry. 477(12). 2829–2839. 9 indexed citations
9.
Lü, Xing, Hao Cheng, Qiming Xu, & Xiangshi Tan. (2021). Encapsulation of STING Agonist cGAMP with Folic Acid-Conjugated Liposomes Significantly Enhances Antitumor Pharmacodynamic Effect. Cancer Biotherapy and Radiopharmaceuticals. 38(8). 543–557. 8 indexed citations
10.
Liu, Weiwei, Lin Liao, Wenrui Liu, et al.. (2021). The Expression of TRIM6 Activates the mTORC1 Pathway by Regulating the Ubiquitination of TSC1-TSC2 to Promote Renal Fibrosis. Frontiers in Cell and Developmental Biology. 8. 616747–616747. 20 indexed citations
11.
Cheng, Hao, Qiming Xu, Xing Lü, et al.. (2020). Activation of STING by cGAMP Regulates MDSCs to Suppress Tumor Metastasis via Reversing Epithelial-Mesenchymal Transition. Frontiers in Oncology. 10. 896–896. 44 indexed citations
12.
Xu, Qiming, Wei Xu, Hao Cheng, Hong Yuan, & Xiangshi Tan. (2019). Efficacy and mechanism of cGAMP to suppress Alzheimer’s disease by elevating TREM2. Brain Behavior and Immunity. 81. 495–508. 57 indexed citations
13.
Qin, Jing, Jiangna Guo, Qiming Xu, et al.. (2017). Synthesis of Pyrrolidinium-Type Poly(ionic liquid) Membranes for Antibacterial Applications. ACS Applied Materials & Interfaces. 9(12). 10504–10511. 167 indexed citations
14.
Guo, Jiangna, Qiming Xu, Rongwei Shi, et al.. (2017). Polyanionic Antimicrobial Membranes: An Experimental and Theoretical Study. Langmuir. 33(17). 4346–4355. 34 indexed citations
15.
Zheng, Zhiqiang, Jiangna Guo, Hailei Mao, et al.. (2017). Metal-Containing Poly(ionic liquid) Membranes for Antibacterial Applications. ACS Biomaterials Science & Engineering. 3(6). 922–928. 65 indexed citations
16.
Pan, Jie, Hong Yuan, Xiaoxue Zhang, et al.. (2017). Probing the Molecular Mechanism of Human Soluble Guanylate Cyclase Activation by NO in vitro and in vivo. Scientific Reports. 7(1). 43112–43112. 14 indexed citations
17.
Pan, Jie, Xiaoxue Zhang, Hong Yuan, et al.. (2016). The molecular mechanism of heme loss from oxidized soluble guanylate cyclase induced by conformational change. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1864(5). 488–500. 23 indexed citations
18.
Li, Tiejun, Hao Cheng, Hong Yuan, et al.. (2016). Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response. Scientific Reports. 6(1). 19049–19049. 201 indexed citations
19.
Zhao, Yaqin, Qiming Xu, Wei Xu, et al.. (2015). Probing the molecular mechanism of cerium oxide nanoparticles in protecting against the neuronal cytotoxicity of Aβ1–42 with copper ions. Metallomics. 8(7). 644–647. 9 indexed citations
20.
Pan, Jie, Qiming Xu, Ying‐Wu Lin, Fangfang Zhong, & Xiangshi Tan. (2013). Human soluble guanylate cyclase as a nitric oxide sensor for NO-signalling reveals a novel function of nitrite reductase. Chemical Communications. 49(67). 7454–7454. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026